Zhong Yuan Bio-Technology Holdings Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ZHYBF research report →
Companywww.zybioholdings.com
Zhong Yuan Bio-Technology Holdings Limited engages in the development and marketing of nervonic acid-based health supplements in China. The company's products include Neuro Enhancer nervonic acid oils, Muzhiyuan acer truncatum formula oils, Life's NA candies, and seedlings of Acer Truncatum. In addition, it offers demyelination diagnostic kit and nervonic acid supplement.
- CEO
- Ting Ting Chang
- IPO
- 2021
- Employees
- 23
- HQ
- Wan Chai, HK
Price Chart
Valuation
- Market Cap
- $35.75M
- P/E
- 118.63
- P/S
- 15.69
- P/B
- -175.27
- EV/EBITDA
- 80.45
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 90.94%
- Op Margin
- 11.70%
- Net Margin
- 13.27%
- ROE
- -109.67%
- ROIC
- 10.11%
Growth & Income
- Revenue
- $2.28M · 37.03%
- Net Income
- $302.21K · 113.55%
- EPS
- $0.02 · 114.17%
- Op Income
- $266.56K
- FCF YoY
- 26.99%
Performance & Tape
- 52W High
- $2.02
- 52W Low
- $2.00
- 50D MA
- $2.02
- 200D MA
- $2.02
- Beta
- 4.10
- Avg Volume
- 85.832
Get TickerSpark's AI analysis on ZHYBF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our ZHYBF Coverage
We haven't published any research on ZHYBF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ZHYBF Report →